amodiaquine-artesunate (ASAQ)

DRUG3 trials

Sponsors

Institute of Tropical Medicine, Belgium, Medecins Sans Frontieres, Netherlands, Centers for Disease Control and Prevention

Conditions

FeverMalariaPlasmodium FalciparumUncomplicated Malaria

Phase 3

Evaluation of 4 Artemisinin-based Combinations for Treating Uncomplicated Malaria in African Children

CompletedNCT00393679

Institute of Tropical Medicine, BelgiumFever, Malaria

Start: 2007-07-31End: 2009-12-31Updated: 2014-02-03

Phase 4

Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for Uncomplicated Malaria in South Kivu, DR Congo

CompletedNCT02741024

Medecins Sans Frontieres, NetherlandsMalaria

Start: 2013-10-31End: 2014-12-31Updated: 2016-04-18

Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for Treatment of Plasmodium Falciparum Malaria in Liberia

CompletedNCT06300970

Centers for Disease Control and PreventionMalaria, Plasmodium Falciparum, Uncomplicated Malaria

Start: 2022-08-09End: 2023-08-16Updated: 2024-05-07

Related Papers

In vivo efficacy of artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria: an open-randomized, non-inferiority clinical trial in South Kivu, Democratic Republic of Congo.

2016-09-0616 citations

Efficacy of quinine, artemether-lumefantrine and dihydroartemisinin-piperaquine as rescue treatment for uncomplicated malaria in Ugandan children.

2013-01-2225 citations

A head-to-head comparison of four artemisinin-based combinations for treating uncomplicated malaria in African children: a randomized trial.

2011-11-08120 citations